Condition: Mitral Valve Regurgitation · Sponsor: Medtronic Cardiovascular
Multi-center, global, prospective, non-randomized, interventional, pre-market trial. All subjects enrolled with receive the study device.
This description comes directly from the study's public registry record.
Megan Wilder Fredrickson · 612-469-1749 · rs.tmvrpivotaltrial@medtronic.com
Always discuss trial participation with your own doctor first.
| University of Alabama Birmingham (UAB) Hospital | Birmingham, Alabama, United States | Recruiting |
| Abrazo Heart Hospital | Phoenix, Arizona, United States | Recruiting |
| Scripps Memorial Hospital | La Jolla, California, United States | Recruiting |
| PIH Health Good Samaritan Hospital | Los Angeles, California, United States | Recruiting |
| Kaiser Permanente Los Angeles Medical Center | Los Angeles, California, United States | Recruiting |
| Keck Hospital of the University of Southern California, USC | Los Angeles, California, United States | Recruiting |
| Cedars Sinai Medical Center | Los Angeles, California, United States | Recruiting |
| El Camino Hospital | Mountain View, California, United States | Recruiting |
| Kaiser Permanente San Francisco Medical Center | San Francisco, California, United States | Recruiting |
| Stanford Hospital and Clinics | Stanford, California, United States | Recruiting |
| Los Robles Regional Medical Center | Thousand Oaks, California, United States | Recruiting |
| Hartford Hospital | Hartford, Connecticut, United States | Recruiting |
+ 73 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03242642